Related Experiment Video
Updated: May 2, 2026
06:55
Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
8.9K
Liver disease secondary to intestinal failure
Bassam Abu-Wasel1, Michele Molinari1
1Queen Elizabeth II Health Sciences Centre, Dalhousie University, 1276 South Park Street, Office 6-302 Victoria Building, Halifax, NS, Canada B3H 2Y9.
Biomed Research International
|February 20, 2014
Summary
Intestinal failure-associated liver disease (IFALD) is a serious risk for patients needing long-term parenteral nutrition (PN). Optimizing PN, multidisciplinary care, and timely transplantation can reduce IFALD incidence and improve survival.
Area of Science:
- Hepatology
- Gastroenterology
- Surgical Sciences
Background:
- Intestinal failure-associated liver disease (IFALD) is a frequent and severe complication in patients with short bowel syndrome (SBS) dependent on long-term parenteral nutrition (PN).
- Managing IFALD is critical for patient survival and quality of life.
Purpose of the Study:
- To review strategies for decreasing the incidence of IFALD in patients with SBS on long-term PN.
- To highlight the importance of a multidisciplinary approach and early referral for intestinal-liver transplantation.
Main Methods:
- Literature review of current management strategies for IFALD.
- Analysis of factors influencing IFALD development and progression.
- Evaluation of the role of parenteral nutrition optimization and transplantation.
Main Results:
- Optimizing parenteral solution composition and infusion rates can mitigate IFALD risk.
- A coordinated, multidisciplinary approach is essential for comprehensive patient care.
- Early consideration for intestinal-liver transplantation offers a life-saving option for eligible patients.
Conclusions:
- IFALD incidence can be reduced through proactive management strategies.
- Multidisciplinary care and timely intestinal-liver transplantation are key to ensuring long-term survival for SBS patients at risk of IFALD.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
01:07Intestinal Obstruction II: Pathophysiology
47
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
47
01:17Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
01:26Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
01:21Chronic Pancreatitis II: Pathophysiology
30
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
30